Congo vs Mauritania: Antiretroviral therapy coverage for PMTCT
Congo
42.0%
in 2024
Mauritania
39.0%
in 2024
Congo rank
70th
Mauritania rank
73rd
Antiretroviral therapy coverage for PMTCT over time
- Congo
- Mauritania
How they compare
Congo currently reports 42.0% against 39.0% in Mauritania, a difference of 3.0%.
That makes Congo's figure about 1.1 times Mauritania's.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Congo ranks 70th and Mauritania ranks 73rd of 84 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Mauritania in 2.
Head to head by decade
| Decade | Congo | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 2.0% | 3.2% | Congo |
| 2010s | 15.4% | 25.1% | 9.7% | Mauritania |
| 2020s | 27.0% | 28.4% | 1.4% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Congo or Mauritania?
- Congo, at 42.0% against 39.0% in Mauritania as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Congo and Mauritania?
- 3.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Mauritania rank globally for antiretroviral therapy coverage for pmtct?
- Congo ranks 70th and Mauritania ranks 73rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).